As part of the 14th International Symposium on Ocular and Pharmacological Therapeutics, a unique panel was gathered to discuss two cardinal questions related to the treatment of glaucoma, peeking into the future: (1) What shape and form will glaucoma medical treatment have five and fifteen years from today, and (2) Will personalized medicine be commonly used five years from now.
For each of the questions, we assigned an “optimist” and “pessimist” who provided the assigned point of view, for a total of 4 discussants, the authors of this panel discussion
